An Interview With Oncology Clinical Pharmacist John Valgus, PharmD, BCOP, CPP
UNC Lineberger Primary Benefactor for the Wachovia Tar Heel 10 Miler - Chapel Hill's Largest Running Event
Technology developed by UNC Lineberger members may lead to diagnostic test
Group Walks to Honor Emily Kleisch Crawford of Chapel Hill
Resulting Database to Yield Big Gains for Genetic Scientists
Normal humans produce a novel, circular form of non-coding RNA that regulates aging
UNC Hospitals is one of 378 facilities in the world, and among only 6 percent of all U.S. hospitals, that have earned Magnet designation.
Organization will receive The Artist in Residence Program to help people affected by cancer
G-Zero Therapeutics funded under Qualifying Therapeutic Discovery Project
In a study published this month in the Journal of Clinical Oncology, the results of a clinical trial of the drug bevacizumab to treat colon cancer in combination with the standard therapy found that the drug did not significantly increase disease-free survival in patients with stage II and stage III colon cancer.
Cell signaling protein may hold key to blocking long-studied genetic mutation
$11.9 Million in awards to address cancer disparities